| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/24/2003 | CA2489726A1 Diagnosis and treatment of chemoresistant tumors |
| 12/24/2003 | CA2489724A1 Immunogenic conjugates |
| 12/24/2003 | CA2489645A1 Pokeweed antiviral protein polypeptides with antiviral activity |
| 12/24/2003 | CA2489605A1 Oxaliplatin anti-resistance agent |
| 12/24/2003 | CA2489595A1 Recombination of nucleic acid library members |
| 12/24/2003 | CA2489594A1 Inhibitors of inflammatory gene activity and cholesterol biosynthesis |
| 12/24/2003 | CA2489474A1 Method for predicting a drug transport capability by abcg2 polymorphisms |
| 12/24/2003 | CA2489469A1 Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer |
| 12/24/2003 | CA2489467A1 Humanized monoclonal antibody hpam4 |
| 12/24/2003 | CA2489464A1 Methods of producing dna and protein libraries |
| 12/24/2003 | CA2489440A1 Anti-igf-i receptor antibody |
| 12/24/2003 | CA2489378A1 Methods, systems, and computer program products for simulating biomembranes using coarse grain models |
| 12/24/2003 | CA2489346A1 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis a viral nucleic acid |
| 12/24/2003 | CA2489316A1 Antibody and inhibitor, and transfection method or kit using them |
| 12/24/2003 | CA2489296A1 Methods for the identification of allo-antigens and their use for cancer therapy and transplantation |
| 12/24/2003 | CA2489292A1 Vectors for expression of hml-2 polypeptides |
| 12/24/2003 | CA2488924A1 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter |
| 12/24/2003 | CA2488916A1 Xylanases, nucleic acids encoding them and methods for making and using them |
| 12/24/2003 | CA2488896A1 Multifunctional polypeptides |
| 12/24/2003 | CA2488876A1 Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets |
| 12/24/2003 | CA2488821A1 Methods and compositions for grafting functional loops into a protein |
| 12/24/2003 | CA2487809A1 Aptamer-toxin molecules and methods for using same |
| 12/24/2003 | CA2487321A1 Specificity grafting of a murine antibody onto a human framework |
| 12/24/2003 | CA2486420A1 Compositions and methods for detecting hepatitis b virus |
| 12/23/2003 | US6667428 Introducing a nucleic acid by enriching or selection for a plant cell population having a nuclear DNA phase of 4C; and contacting the population with Agrobacterium having a T-DNA which includes the nucleic acid |
| 12/23/2003 | US6667427 Genetic manipulation of plants with genes and promoters that enhance disease resistance. |
| 12/23/2003 | US6667426 Grapevine fanleaf virus resistance in grapevine expressing grapevine fanleaf virus coat protein |
| 12/23/2003 | US6667295 DNA vaccine against feline immunodeficiency virus |
| 12/23/2003 | US6667294 Freeze drying aqueous solution |
| 12/23/2003 | US6667176 cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
| 12/23/2003 | US6667174 Expression vectors containing hybrid ubiquitin promoters |
| 12/23/2003 | US6667173 Antiscarring agents; wound healing agents |
| 12/23/2003 | US6667170 Sequences of Xylanase and Xylanase expression vectors |
| 12/23/2003 | US6667169 Polypeptides having acid phosphatase activity and nucleic acids encoding same |
| 12/23/2003 | US6667166 Preparing pantothenic acid; obtain genetically engineered bacteria, culture, express phosphofructokinase, recover pantothenic acid |
| 12/23/2003 | US6667165 Method and compositions for reversible inhibition of thermostable polymerases |
| 12/23/2003 | US6667163 Genetic engineering |
| 12/23/2003 | US6667162 Isolating the Fkhsf polypeptide from cultured recombinant host cells. |
| 12/23/2003 | US6667155 Particle for the detection of preferential nucleotide sequences; for monitoring treatment of viral diseases |
| 12/23/2003 | US6667152 Method for selective inactivation of viral replication |
| 12/23/2003 | US6667150 Screening for polyphage particles that contain the combination; the two members of the multimeric polypeptide complex interact to form an immunoglobulin, and wherein said predetermined property is the ability to bind to a target |
| 12/23/2003 | US6667039 Delivering therapeutic agent to CD30+ malignant cells by contacting with conjugate comprising one or more agents attached to soluble CD30 ligand polypeptide having specified amino acid sequence |
| 12/23/2003 | US6667038 Isolated peptide comprising specified amino acid sequence |
| 12/23/2003 | US6667037 Isolated peptides which bind to HLA-B35 molecules, larger peptides which contain these, nucleic acid molecules encoding peptides, and uses thereof |
| 12/23/2003 | US6667035 Isolated polypeptide which specifically binds and neutralizes Clostridium difficile enterotoxin (toxin A) |
| 12/23/2003 | US6667034 Human gene therapy; culture product; adjustment of metabolism; regeneration bone marrow |
| 12/23/2003 | US6667032 For diagnosis of disorders |
| 12/23/2003 | CA2322073C Method for the non-specific amplification of nucleic acid |
| 12/23/2003 | CA2301575C Vectors and methods for immunization or therapeutic protocols |
| 12/23/2003 | CA2173861C Reaction tube and method of use to minimize contamination |
| 12/23/2003 | CA2087342C Serine protease variants having peptide ligase activity |
| 12/20/2003 | CA2431579A1 Labeling of objects to be identified consisting of at least one dna fragment |
| 12/19/2003 | WO2002101076A2 Methods for targeted expression of therapeutic nucleic acid |
| 12/19/2003 | CA2460095A1 Methods for targeted expression of therapeutic nucleic acid |
| 12/18/2003 | WO2003104818A1 Method for identifying agonists or antagonists for the g-protein coupled mas-like 1 receptor |
| 12/18/2003 | WO2003104811A2 Diagnostic and therapeutic use of steroidogenic acute regulatory protein for neurodegenerative diseases |
| 12/18/2003 | WO2003104807A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 12/18/2003 | WO2003104494A1 Methods for blocking adipocyte differentiation and triglyceride accumulation with g-alpha-i3 inhibitors |
| 12/18/2003 | WO2003104493A1 Improvements in and relating to a method of dna testing for mycobacterium paratuberculosis strains |
| 12/18/2003 | WO2003104490A2 Method for the simultaneous detection of hybridization and vaccination reactions and diagnostic uses thereof |
| 12/18/2003 | WO2003104484A1 Methods of treating and diagnosing diabetes with cx3cr1 modulators |
| 12/18/2003 | WO2003104480A1 Method for identifying agonists or antagonists for the gpr45-like/gpr63 receptor |
| 12/18/2003 | WO2003104476A2 Assay to detect replication competent viruses |
| 12/18/2003 | WO2003104470A2 Retrons for gene targeting |
| 12/18/2003 | WO2003104469A1 Adenovirus vector |
| 12/18/2003 | WO2003104468A1 A semliki forest virus based expression vector for the central nervous system |
| 12/18/2003 | WO2003104467A1 Means and methods for the production of adenovirus vectors |
| 12/18/2003 | WO2003104466A1 Treatment of vascular dysfunction and alzheimer's disease |
| 12/18/2003 | WO2003104465A1 Soybean promoter expressed preferentially in pods |
| 12/18/2003 | WO2003104464A1 Female gametophyte specific promoter (zmea1) |
| 12/18/2003 | WO2003104463A1 Transgenic expression constructs and method for increasing the vitamin e content in plant organisms |
| 12/18/2003 | WO2003104462A2 Regulation of gene expression using chromatin remodelling factors |
| 12/18/2003 | WO2003104461A1 Pigment protein |
| 12/18/2003 | WO2003104460A1 Pigment protein |
| 12/18/2003 | WO2003104459A1 Fcyriia transgenic animal model for autoimmune disease |
| 12/18/2003 | WO2003104458A1 Antisense modulation of il-1 receptor-associated kinase-1 expression |
| 12/18/2003 | WO2003104457A1 Temperature dependent rna splicing in a host cell |
| 12/18/2003 | WO2003104456A1 Immunomodulation using altered dendritic cells |
| 12/18/2003 | WO2003104455A1 Screening methods |
| 12/18/2003 | WO2003104453A1 Method of constructing antibody |
| 12/18/2003 | WO2003104452A1 Method of distinguishing gene participating in stigma exposure ratio in rice and method of modifying stigma exposure ratio in rice |
| 12/18/2003 | WO2003104451A2 Modifying dna recombination and repair |
| 12/18/2003 | WO2003104450A1 Rapid dna selection method |
| 12/18/2003 | WO2003104449A2 Improved method for protein production in plant cells |
| 12/18/2003 | WO2003104448A1 Electroporation device |
| 12/18/2003 | WO2003104446A1 Novel acylase gene |
| 12/18/2003 | WO2003104431A2 Transgenic mammals expressing polyglutamine |
| 12/18/2003 | WO2003104428A2 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 12/18/2003 | WO2003104427A2 Methods and compositions for detecting cancers |
| 12/18/2003 | WO2003104426A2 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
| 12/18/2003 | WO2003104422A2 Mahoganoid polypeptides, and related compositions and methods |
| 12/18/2003 | WO2003104416A2 Spliceosome mediated rna trans-splicing in stem cells |
| 12/18/2003 | WO2003104415A2 Method to screen ligands using eukaryotic cell display |
| 12/18/2003 | WO2003104413A2 Production of pseudotyped recombinant aav virions |
| 12/18/2003 | WO2003104412A2 Spliceosome mediated rna trans-splicing and correction of factor viii genetic defects using spliceosome mediated rna trans spling |
| 12/18/2003 | WO2003104408A2 Commercial production of recombinant manganese-dependent peroxidase in plants |
| 12/18/2003 | WO2003104407A2 T cell receptor cdr3 sequences and methods for detection |
| 12/18/2003 | WO2003104406A2 Improvements for combinatorial oligonucleotide pcr |
| 12/18/2003 | WO2003104405A2 Methods for promoting homologous recombination |
| 12/18/2003 | WO2003104402A2 Non-polymeric hematopoietic cell clots for delivery of active agents |